Douglas Forsyth - Net Worth and Insider Trading

Douglas Forsyth Net Worth

The estimated net worth of Douglas Forsyth is at least $4 Million dollars as of 2024-11-08. Douglas Forsyth is the Director of Inhibrx Biosciences Inc and owns about 224,564 shares of Inhibrx Biosciences Inc (INBX) stock worth over $4 Million. Douglas Forsyth is also the Affiliated Person of Virtus AllianzGI Equity & Convertible Income Fund and owns about 0 shares of Virtus AllianzGI Equity & Convertible Income Fund (NIE) stock worth over $0. Details can be seen in Douglas Forsyth's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas Forsyth has not made any transactions after 2024-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Douglas Forsyth

To

Douglas Forsyth Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas Forsyth owns 11 companies in total, including Inhibrx Inc (INBX) , Virtus AllianzGI Equity & Convertible Income Fund (NIE) , and Virtus Convertible & Income 2024 Target Term Fund (CBH) among others .

Click here to see the complete history of Douglas Forsyth’s form 4 insider trades.

Insider Ownership Summary of Douglas Forsyth

Ticker Comapny Transaction Date Type of Owner
INBX Inhibrx Inc 2020-08-18 director
NIE Virtus AllianzGI Equity & Convertible Income Fund 2020-08-11 other: Affiliated Person
CBH Virtus Convertible & Income 2024 Target Term Fund 2017-06-27 other: Portfolio Manager
LIMIT LIMIT 2015-05-21 other: Affiliated Person
LIMIT LIMIT 2007-08-15 other: Affiliated Person
LIMIT LIMIT 2014-03-13 other: Affiliated Person
LIMIT LIMIT 2014-02-21 other: Affiliated Person
LIMIT LIMIT 2013-04-01 other: Affiliated Person
LIMIT LIMIT 2005-02-23 other: Portfolio Manager
LIMIT LIMIT 2003-07-30 Vice President/Portfolio Mgr.
LIMIT LIMIT 2007-08-15 other: Affiliated Person

Douglas Forsyth Latest Holdings Summary

Douglas Forsyth currently owns a total of 2 stocks. Among these stocks, Douglas Forsyth owns 224,564 shares of Inhibrx Biosciences Inc (INBX) as of August 23, 2024, with a value of $4 Million and a weighting of 100%. Douglas Forsyth also owns 0 shares of Virtus AllianzGI Equity & Convertible Income Fund (NIE) as of August 11, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of Douglas Forsyth

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INBX Inhibrx Biosciences Inc 2024-08-23 224,564 16.26 3,651,411
NIE Virtus AllianzGI Equity & Convertible Income Fund 2020-08-11 0 23.74 0

Holding Weightings of Douglas Forsyth


Douglas Forsyth Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas Forsyth has made a total of 1 transactions in Inhibrx Biosciences Inc (INBX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inhibrx Biosciences Inc is the acquisition of 75,000 shares on August 23, 2024, which cost Douglas Forsyth around $1 Million.

According to the SEC Form 4 filings, Douglas Forsyth has made a total of 1 transactions in Virtus AllianzGI Equity & Convertible Income Fund (NIE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Virtus AllianzGI Equity & Convertible Income Fund is the sale of 20,000 shares on August 11, 2020, which brought Douglas Forsyth around $493,200.

Insider Trading History of Douglas Forsyth

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas Forsyth Trading Performance

GuruFocus tracks the stock performance after each of Douglas Forsyth's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas Forsyth is %. GuruFocus also compares Douglas Forsyth's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas Forsyth within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas Forsyth's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas Forsyth

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.98 LIMIT LIMIT LIMIT LIMIT LIMIT

Douglas Forsyth Ownership Network

Ownership Network List of Douglas Forsyth

No Data

Ownership Network Relation of Douglas Forsyth

Insider Network Chart

Douglas Forsyth Owned Company Details

What does Inhibrx Inc do?

Who are the key executives at Inhibrx Inc?

Douglas Forsyth is the director of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .

Inhibrx Inc (INBX) Insider Trades Summary

Over the past 18 months, Douglas Forsyth made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net purchase of 511,627 shares made by Viking Global Investors Lp , and a net sale of 300,000 shares made by Brendan P. Eckelman .

In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Inhibrx Inc (INBX) were sold and 511,627 shares were bought by its insiders, resulting in a net purchase of 211,627 shares.

Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inhibrx Inc Insider Transactions

No Available Data

Douglas Forsyth Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas Forsyth. You might contact Douglas Forsyth via mailing address: 1633 Broadway, New York Ny 10019.